 Axsome Therapeutics, Inc. NASDAQ:AXSM Q2 2022 Earnings Conference Call August 9, 2022 8:00 AM ET Company Participants Mark Jacobson - Chief Operating Officer Herriot Tabuteau - Founder, Chairman, Chief Executive Officer President Lori Englebert - Executive Vice President of Commercial Business Development Nick Pizzie - Chief Financial Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Yatin Suneja - Guggenheim Partners Jason Gerberry - Bank of America Joseph Thome - Cowen Graig Suvannavejh - Mizuho Securities Chris Howerton - Jefferies Matt Kaplan - Ladenburg Thalmann Myles Minter - William Blair David Hoang - SMBC Operator Good morning, and welcome to the Axsome Therapeutics Conference Call. I would now like to turn the conference over to your host, Mark Jacobson, Chief Operating Officer at Axsome Therapeutics. 